GlassScriptPhysician profile
Elizabeth J Kirlis
NPI 1437126349
$1,030.80
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2021: $78.83 · 2022: $356 · 2023: $325 · 2024: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471 · Long Term Medical Supply Or Device Loan: $15.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.41 |
| Long Term Medical Supply Or Device Loan | $15.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $205.37 | 2022-2024 | Azstarys |
| Glaxosmithkline, LLC. | $167.89 | 2022-2024 | Bexsero, Pediarix |
| Baxter Healthcare | $149.82 | 2022-2024 | Hillrom - Spot Vision Screener |
| Ironshore Pharmaceuticals INC. | $111.31 | 2021-2023 | Jornay Pm |
| Tris Pharma INC | $77.40 | 2022-2023 | Dyanavel Xr |
| Pfizer INC. | $58.72 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $49.49 | 2021 | |
| Nestle Healthcare Nutrition INC. | $43.57 | 2023 | |
| Shire North American Group INC | $39.02 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.75 | 2024 | |
| Sanofi Pasteur INC. | $17.01 | 2024 | |
| Harmony Biosciences LLC | $16.32 | 2023 | Wakix |
| Adlon Therapeutics L.P. | $16.27 | 2019 | |
| Welch Allyn | $14.92 | 2021 | |
| Genentech USA, INC. | $14.64 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.30 | 2024 | Gardasil 9, Rotateq, Gardasil |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Kirlis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.